Upregulation of DDR1 in multiple human cancers including lung, breast, colon, esophagus, brain, ovary and prostate cancers implies that DDR1 is involved in tumor progression [2], [7], [8], [10], [14], [15], [16], [17]. This evidence concerns the gene DDR1 and neoplasm.